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ABSTRACT
Objectives Preventing postoperative recurrence after
ileocolonic resection (ICR) for Crohn’s disease (CD) is
challenging. Deﬁning the disturbances of the microbial
composition and community structure after ICR and their
link with early disease recurrence is crucial.
Design Microbiota composition (ﬁngerprinting and 16S
rDNA sequencing) and community structure (correlation
networks of bacterial species) were assessed from ileal
mucosa sampled in 20 patients undergoing ICR and
6 months later during endoscopy from above
(neoterminal ileum) and below (subanastomotic colon)
the surgical anastomosis.
Results ICR had a dramatic effect on gut microbial
ecosystem. At surgery, CD mucosa harboured a dysbiotic
microbiota with high proportions of α/β Proteobacteria
and Bacilli. Six months later, half of the patients had
recurrent lesions at ileocolonoscopy and presented higher
numbers of Lachnospiraceae. Recurrence of endoscopic
lesions was associated with enrichment in Enterococcus
durans while patients in remission had increased
proportions of Dorea longicatena and Bacteroides
plebeius. Structural differences were striking between
recurrence and remission microbiota; while the
microbiota of patients with CD recurrence exhibited a
loose community structure, the microbiota of patients in
remission displayed communities that were robustly
correlated to each other. Microbiota colonising the
neoterminal ileum and subanastomotic colon 6 months
after ICR only differed in patients with recurrence.
Conclusions ICR modiﬁes the gut microbiome.
Remission after 6 months was associated with
homogenous bacterial distribution around the
anastomosis. Community structure and bacterial
networks highlight target species, including
Faecalibacterium prausnitzii and Ruminococcus gnavus,
which may allow precise modulations of the overall
microbial ecosystem towards remission pattern.
INTRODUCTION
Crohn’s disease (CD) is a chronic inﬂammatory
disease of the intestine with an increasing incidence
worldwide.1 It is a multifactorial disease where
host genetic impairments and environmental trig-
gers lead to the onset and maintenance of inappro-
priate host immune responses at the gut mucosa
interface.
More than 70 genetic loci have been linked to
CD phenotype transmission,2 and interestingly,
most of them involve several key host defences
(NOD2, IL23R, ATG16L1, FUT2). Environmental
factors, especially smoking habits, are also involved.
Results obtained from experimental mouse models3
have shed light on different mechanisms emphasis-
ing a failure in the host–microbiota crosstalk.
Host–microbiota interactions sustain numerous
physiological functions such as the maturation of
host intestinal/immune cells (lymphoid tissue,
Paneth cells) and the settlement of a commensal
microbiota, thereof any alteration of this intimate
relationship might modify the natural makeup of
the ‘healthy’ microbiome. The use of immunologic-
ally impaired animal models has emphasised the
importance of this relationship. For instance,
TRUC mice (T-bet−/− RAG2−/− UC model) are
able to shape an aberrant microbiota leading to
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Signiﬁcance of this study
What is already known on this subject?
▸ Recurrence of Crohn’s disease (CD) after
ileocolonic resection (ICR) is frequent.
▸ Luminal ﬂux and gut microbiota are involved in
this setting.
What are the new ﬁndings?
▸ ICR for CD strongly modiﬁes the gut mucosal
microbiota.
▸ Spatial homogeneity in bacterial composition
around the anastomosis is associated with
maintenance of endoscopic remission.
▸ Microbial community structure and bacterial
species assemblages are cohesive during
remission while a loose structure, together with
a cluster of bacteria from the Proteobacteria
phylum, is associated with endoscopic
recurrence.
How might it impact on clinical practice in
the foreseeable future?
▸ Bacterial recolonisation following ICR might
pave the way towards remission or recurrence.
▸ Community structure and bacterial networks
highlight target species that may allow precise
modulations of the overall microbial ecosystem
towards remission pattern.
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disease4 5 and the transfer of their microbiota to a wild type
host was shown as well to induce colitis.5 6
Corticosteroids, thiopurines and monoclonal antibodies
against tumour necrosis factor-α are efﬁcient to modulate
inﬂammatory activity, but surgery is still frequently required.7
Strikingly, severe inﬂammatory lesions recur in the neoterminal
ileum in the months following surgery in more than half of the
patients operated on to remove the inﬂamed ileum.8 9 The
crucial link between gut microbiota and CD recurrence was ﬁrst
suspected in this context two decades ago.10 11 In ﬁve patients
with CD who had undergone resection with a diverting loop ile-
ostomy proximal to an ileocolonic anastomosis, lesions recurred
in the neoterminal ileum only once the bowel continuity was
restored, which suggested that the microbiota and/or other com-
ponents of the faecal stream may play a role.
The importance of the human gut microbiome in health and
disease has been recognised for decades.12–15 In CD, it seems of
great interest to investigate the mucosal microbiota that differs
from faecal samples16 as it is in close contact to the disease
process. In this study, we aimed at (i) assessing the impact of the
ileocolonic resection (ICR) on the mucosa-associated micro-
biota, (ii) observing whether alterations differed between
patients in remission or in recurrence after ICR, (iii) highlight-
ing bacterial biomarkers of early recurrence of inﬂammatory
lesions, and ﬁnally, (iv) deciphering bacterial community struc-
ture at the mucosal level in patients.
Microbial proﬁling and in-depth sequencing techniques were
applied to analyse the gut microbiota. Since ecological con-
straints in the gut (chemical, immunological or trophic) are
crucial in shaping the microbiota assembly and necessary for the
development of a structured and functional ecosystem, we
analysed the microbiota for its composition, diversity and struc-
ture in patients suffering from CD before and 6 months follow-
ing operation to track out any change in microbiota
composition and decipher the microbial recolonisation process
following ICR.
PATIENTS AND METHODS
Patients and samples
Twenty patients with active CD were included in this study.
They were part of a double-blind, randomised, placebo-
controlled, 6-month clinical study,17 aiming at assessing the efﬁ-
cacy of the probiotic strain Lactobacillus johnsonii LA1 to
decrease the endoscopic recurrence rate 6 months after surgery.
CD was diagnosed on the basis of standard clinical, radio-
graphic, endoscopic and pathological criteria. The patients had
to be addressed to clinical centres for ileal or ICR. Patients who
received antibiotics during the previous three months or receiv-
ing antibiotics for >2 weeks after surgery were not eligible.
Other exclusion criteria included (i) total or subtotal colectomy,
intestinal bypass or stricturoplasty, stomy, carcinoma resection,
or abscess drainage; (ii) treatment with aminosalicylates or
immunosuppressants >3 weeks following surgery; (iii) any other
disease or condition that might interfere with the study assess-
ments (as judged by the investigator); and (iv) child-bearing
potential in women not using effective contraception; and preg-
nant or lactating women.
At time of surgery (month 0 (M0)), patients provided faecal
samples before colonic cleansing. Biopsies were sampled using
biopsy pinches from the fresh resected tissue at the ileal level in
macroscopically ulcerated regions. Tissue specimens were also
collected (4 cm2 surface). Patients were examined 6 months
after ICR (month 6 (M6)), provided faecal samples and an ileo-
colonoscopy was performed. Biopsies were sampled from the
neoterminal ileum (above the anastomosis) and the subanasto-
motic colon (below the anastomosis). Endoscopic status was
determined (recurrence of inﬂammatory lesions (REC); remis-
sion (REM)). Endoscopic recurrence was deﬁned by a Rutgeerts
score >2.18 All samples were immediately dry frozen in nitro-
gen or dry ice and further kept at −80°C before analysis. At
1-year follow-up, endoscopic and clinical recurrence was
assessed by clinicians.
DNA preparation
Total DNA was extracted from faeces and biopsy samples as pre-
viously described.19 DNA concentration and integrity were
determined spectrophotometrically and bacterial 16S rRNA
gene was ampliﬁed using either primers targeting the V6-V8
region (GCclamp-U968 and L1401) for ﬁngerprinting20 or the
V3-V4 region for sequencing (V3fwd: 50-TACGGRAG
GCAGCAG-30, V4rev: 50-GGACTACCAGGGTATCTAAT-30).21
Fingerprinting of the dominant microbiota
Sequence-speciﬁc ﬁngerprints were obtained with Temporal
Temperature Gradient Gel Electrophoresis (TTGE) as previously
described.19 TTGE proﬁles were analysed with Gel Compar
software V.2.0 (Applied Maths, Kortrijk, Belgium). Similarity
indexes (Pearson correlation method with unweighted pair
group method with arithmetic mean (UPGMA) method) were
calculated for each pair of proﬁles. Means were compared using
paired Student’s t test when the variances were equal, and other-
wise using Wilcoxon’s test.
Microbial composition assessment by high-throughput
sequencing
Ten patients (ie, 46 samples: 26 mucosal samples and 20 faecal
samples; see online supplementary table S1) were selected from
the main cohort and their microbiota composition was further
deeply analysed by 454 pyrosequencing using GS-FLX-Titanium
technology following manufacturer’s instructions (Roche) for
mucosal samples or MiSeq (Illumina) for faecal samples. Faecal
samples from one patient provided low number of sequences
and were discarded. Sequences were trimmed for adaptors and
PCR primers removal and binned for a minimal sequence length
of 250 bases and an average minimal base quality threshold set
at 25. Resulting sequences (in average 2915 for mucosal
samples and 16 532 for faecal samples) were clustered at 97%
of identity using QIIME22 and usearch (V.5.2.32) pipeline.23
Operational taxonomic units (OTUs) with abundance lower
than four reads were discarded. Chimera detection and removal
were assessed using GOLD reference database and uchime.23
OTUs were assigned to closest taxonomic neighbours using
SEQMATCH and up to date 16S rRNA gene RDP database
(release 10, update 30).24 Alpha diversity (Shannon index) was
analysed on the OTU table rareﬁed to 1000 reads.
All statistical analyses were performed using R program,25
ade426 and igraph packages.27 Statistics was assessed using
either a Wilcoxon’s test or the analysis of variance (p<0.05). If
required, p values were adjusted for multiple testing effects
using the Bonferroni correction. Principal component and
between-class analyses were performed to map each sample
based on their overall microbial composition and to assess simi-
larities between individual’s microbiota. Robustness of each clus-
tering result was assessed using a Monte Carlo rank test
(p<0.05). The network analysis was carried out with SparCC28
(bootstrap n=500) on the most abundant OTUs (maximum
abundance of a particular OTU within a sample ≥0.125%).
SparCC correlation scores ≤−0.5 or ≥0.5 with a p≤0.001 were
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kept for networks inference. The analysis was conducted as
described in the igraph package. Network visualisation was per-
formed using the Fruchterman–Reingold layout algorithm.
Clusters were detected with cluster_louvain() function.29 The
robustness of each cluster was tested (Wilcoxon test) by compar-
ing the number of OTU edges within a deﬁned cluster to the
number of OTU edges outside this cluster.
RESULTS
Twenty patients were included in the study. Six months after
surgery, 10 patients had developed recurrence of CD lesions
(REC) visible during endoscopic examination while the other
half remained in endoscopic remission (REM) according to the
Rutgeerts score. A total of 337 OTUs was detected in mucosal
samples with an average of 88±34 OTUs per sample, while
1225 OTUs constituted the faecal microbiota with an average of
327±124 OTUs per sample. Bacterial phylotypes (or OTUs)
were deﬁned as groups of sequences sharing at least 97% of
similarity and OTUs’ representative sequences were phylogenet-
ically afﬁliated to their closest relative bacterial species.
ICR for CD affects the mucosal microbiota, which is also
depicted in faecal samples
ICR had a striking effect on gut microbial composition.
Bacterial proﬁles of the dominant mucosal microbiota at
6 months after ICR (M6) differed markedly from the proﬁles
observed at time of surgery (M0). The average TTGE pairwise
similarity percentages were 55.1%±25.0% between ileal
mucosa at M0 and the neoterminal ileum at M6, and 48.1%
±28.9% between ileal mucosa at M0 and subanastomotic colon
at M6. The composition of mucosal microbiota, analysed by
16S rRNA gene pyrosequencing, was strongly affected by ICR
(ﬁgure 1). Samples collected at M0 were signiﬁcantly enriched
in bacteria belonging to α-/β-Proteobacteria and Bacilli
(Streptococcus), whereas M6 samples had higher proportions of
Clostridia (see online supplementary table S2 and supplemen-
tary ﬁgure S1). Lachnospiraceae family displayed the largest
variation between M0 and M6 with percentages ranging from
7.39%±2.79% (M0) to 31.01%±7.82% (REC) and 27.17%
±4.78% (REM). Top-down taxonomic analysis emphasised that
Dorea and Blautia genera accounted mostly for this variation.
Strikingly, Porphyromonadaceae levels were also increased in
M6 samples, but only in patients with endoscopic recurrence.
At OTU level, 27 bacterial species were differentially abundant
between M0 and M6 sampling times (table 1; M0=17 OTUs
and M6=10 OTUs).
At M0, the intestinal mucosa of patients with CD harboured
high proportions of unusual, facultative anaerobic or aerobic gut
bacteria such as Streptococccus mitis, Undibacterium oligocarbo-
niphilum, Sphingomonas melonis and Gemella haemolysans.
On the other hand, 6 months after ICR, mucosal samples
exhibited higher levels of anaerobic bacteria belonging to
Lachnospiraceae: Clostridium nexile, Blautia wexlereae and
Dorea longicatena. Bacteroidaceae, Enterobacteriaceae and
Biﬁdobacteriaceae were not impacted by ICR.
No difference was observed within the α-diversity between
M0 and M6 samples (Shannon index, M0: 2.538±0.3179 and
M6: 3.030±0.111, p>0.05).
ICR also impacted faecal bacterial populations, and the
average TTGE proﬁles similarity percentage between M0 and
M6 was 41.3%±34.1%. The inter-individual variability was
high and similarity ranged from 0% to 94.9% between M0 and
M6. No signiﬁcant differences were noticeable depending on
the endoscopic status at 6 months (remission or recurrence).
Average TTGE proﬁles similarity percentages were 45.1%
±23.4% for patients in remission and 58.1%±30.1% for
patients with endoscopic recurrence.
Towards a link between bacterial dysbiosis and
postoperative recurrence
The mucosa-associated microbiota was analysed in detail by 16S
rRNA gene sequencing in 10 patients: 5 having persistent endo-
scopic remission and 5 with recurrence. No signiﬁcant differ-
ence was observed between REC and REM α-diversity
(Shannon index, REC: 2.907±0.513 and REM: 3.131±0.485,
p>0.05). The mucosal microbiota differed markedly between
these two groups of patients. Remission status was characterised
by an increased number of bacteria belonging to four genera
(Bacteroides, Dorea, Ruminococcus and Dialister; see online
supplementary table S3) and mainly the species D. longicatena
and Bacteroides plebeius (table 2). On the other hand,
Gemmiger formicilis, Enterococcus durans and Ruminococcus
lactaris were signiﬁcantly increased in REC patients as were bac-
teria belonging to Bacilli class.
All but 4 of these 14 speciﬁc species (Clostridium bolteae,
Bacteroides dorei, Ruminococcus schinkii and Clostridium ther-
mocellum) were also detected in faecal samples from the
patients although at lower percentages. A similar trend in being
over-represented or under-represented in remission or recur-
rence was observed in faeces but statistical signiﬁcance was not
reached. We searched for bacterial biomarkers of the clinical
outcome in faecal samples of patients at M0 before surgery and
detected signiﬁcant differences in the bacterial composition of
faecal samples at M0 between patients that appeared to stay in
Figure 1 Impact of ileocolonic resection on mucosal microbiota:
initial stage compared with 6 months later. Between class analysis (axis
1 and 2) visualising results from the principal component analysis
based on the operational taxonomic unit composition in the microbiota
of patients before and after surgery (M0 vs M6). Samples were
clustered according to remission/recurrence (REM/REC) and sampling
times (M0 and M6). Robustness of the clustering result was assessed
using a Monte Carlo ranking test. Samples at M0 (REM-0/REC-0) are in
blue. Samples at 6 months for patients in remission (REM-6) are in
green. Samples at 6 months for patients in recurrence (REC-6) are in
red. At M6: sus, neoterminal ileum; sub, subanastomotic colon.
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remission after ICR compared with those who ﬁnally experi-
enced endoscopic recurrence. At the OTUs level, four speciﬁc
molecular species had a biomarker potential, two for remission
prediction and two for recurrence prediction (ﬁgure 2A). While
detection of Coprococcus catus L8 and a relative of Clostridiales
bacterium DJF_B152 (Butyricicoccus genus) in faeces of patients
at M0 were signiﬁcantly associated with remission at M6, the
presence of Proteus mirabilis and of a relative of Eubacterium
rangiferina were highlighted as biomarkers of future recurrence
in patients undergoing ICR (OTUs denovo1092, 326, 423 and
861, respectively). Moreover, OTU denovo1092 and
denovo326 were signiﬁcantly more represented at M0 in
patients being in remission at M6 than in REC patients
(p=0.034 and 0.044, respectively; ﬁgure 2B).
Postoperative recurrence: from microbial dysbiosis to
microbiota destructuration
Unravelling interactions among different species within ecosys-
tems is essential to understand how microbiota responds/adapts
to environmental changes. Here we describe the use of SparCC
correlation-based approach to infer species association
(network) for the mucosal microbiota at each clinical status time
points (M0, REC, REM). Species co-occurrence and exclusion
are assessed at the overall ecosystem level, and groups of highly
correlated OTUs are further deﬁned as clusters. Clusters may
relate to metabolic entities involved in trophic chains or
immune reactions, speciﬁc bacterial features such as aggregation,
signalling, bioﬁlm formation or speciﬁc habitat characteristics
(pH, mucins). Out of 387 total OTUs, only 15 made up the
mucosal microbiota community structure of the patients with
CD before operation (M0, see online supplementary ﬁgure S2
and supplementary table S6). Eighty-seven per cent of these
OTUs (n=13) were common to the mucosal microbiota
Table 1 Differentially represented OTUs between samples collected at time 0 and 6 months after ICR
OTUs Closest species (% of sequence similarity) Time 0 REC6 REM6 p Value
28 Streptococcus mitis (100%) 11.41±5.6 1.63±1.0 0.44±0.2 0.009
58 Undibacterium oligocarboniphilum (100%) 4.58±2.5 0.8±0.3 0.30±0.1 0.021
68 Sphingomonas melonis (100%) 1.81±1.0 0.41±0.2 0.11±0.1 0.027
64 Gemella haemolysans (100%) 1.78±0.8 0.30±0.2 0.06±0.0 0.006
87 Clostridium lituseburense (98%) 1.70±0.9 0.00±0.0 0.01±0.0 0.006
91 Thermus scotoductus (100%) 1.53±0.7 0.73±0.4 0.06±0.0 0.028
76 Mesorhizobium australicum (99%) 1.41±0.7 0.18±0.1 0.07±0.0 0.008
124 Granulicatella adiacens (100%) 1.21±0.7 0.18±0.1 0.03±0.0 0.028
250 Staphylococcus warneri (100%) 0.72±0.4 0.12±0.0 0.06±0.0 0.041
142 Granulicatella elegans (100%) 0.63±0.3 0.04±0.0 0.02±0.0 0.006
224 Bradyrhizobium yuanmingense (100%) 0.56±0.2 0.07±0.1 0.03±0.0 0.002
227 Sediminibacterium salmoneum (96%) 0.46±0.2 0.02±0.0 0.05±0.0 0.011
226 Sediminibacterium salmoneum (98%) 0.38±0.2 0.00±0.0 0.02±0.0 0.032
243 Pseudomonas flavescens (100%) 0.28±0.2 0.01±0.0 0.01±0.0 0.027
256 Rhodospirillum rubrum (86%) 0.21±0.1 0.06±0.0 0±0 0.035
233 Turicibacter sanguinis (100%) 0.08±0.0 0±0 0.02±0.0 0.017
15 Eubacterium coprostanoligenes (92%) 0.03±0.0 0±0 0±0 0.033
10 Clostridium nexile (100%) 0.14±0.0 4.79±1.5 0.83±0.4 0.005
9 Blautia wexlereae (100%) 0.32±0.1 2.81±1.2 4.17±0.8 0.036
12 Dorea longicatena (100%) 0.40±0.2 0.47±0.2 3.18±0.7 0.002
53 Sutterella wadsworthensis (100%) 0.08±0.0 0.27±0.1 0.64±0.2 0.025
199 Ruminococcus schinkii (97%) 0.02±0.0 0.03±0.0 0.24±0.1 0.003
288 Bacteroides dorei (99%) 0±0 0.03±0.0 0.14±0.0 0.035
241 Desulfotomaculum guttoideum (98%) 0.04±0.0 0.00±0.0 0.13±0.0 0.01
1 Bacteroides plebeius (100%) 0.25±0.2 0±0 2.41±0.9 0.029
153 Clostridium bolteae (95%) 0±0 0±0 0.49±0.2 0.034
Shadeless and grey-shaded lines indicate respectively increased OTUs in samples either collected at time 0 or time 6. Statistics was assessed by analysis of variance. Only significant
data (p<0.05) are presented.
ICR, ileocolonic resection; OTUs, operational taxonomic units; REC. recurrence; REM, remission.
Table 2 Differentially represented OTUs between recurrence and
remission samples collected at 6 months after ICR
OTUs
Closest species
(% of sequence similarity) REC6 REM6 p Value
20 Gemmiger formicilis (100%) 1.58±0.7 0.77±0.5 0.038
335 Enterococcus durans (100%) 0.53±0.4 0.00±0.0 0.011
78 Ruminococcus lactaris (96%) 0.32±0.1 0.02±0.0 0.015
12 Dorea longicatena (100%) 0.47±0.2 3.18±0.7 0.011
1 Bacteroides plebeius (100%) 0±0 3.13±1.2 0.013
153 Clostridium bolteae (95%) 0±0 0.49±0.2 0.006
101 Bacteroides dorei (99%) 0.09±0.0 0.47±0.1 0.019
208 Butyricimonas virosa (98%) 0.00±0.0 0.36±0.2 0.05
199 Ruminococcus schinkii (97%) 0.03±0.0 0.24±0.1 0.005
97 Bilophila wadsworthia (100%) 0.01±0.0 0.15±0.1 0.05
237 Bacteroides coprocola (100%) 0±0 0.14±0.1 0.013
241 Desulfotomaculum guttoideum (98%) 0.00±0.0 0.13±0.0 0.013
312 Bacteroides nordii (100%) 0±0 0.12±0.1 0.028
62 Clostridium thermocellum (88%) 0.01±0.0 0.10±0.0 0.021
Shadeless and grey-shaded lines indicate respectively increased OTUs in patients with
disease recurrence or remission. Statistics was assessed by Wilcoxon test. Only
significant data (p<0.05) are presented.
ICR, ileocolonic resection; OTUs, operational taxonomic units; REC. recurrence; REM,
remission.
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structure inferred for the patients 6 months after ICR (see
online supplementary ﬁgure S3). Within the M0 structure, no
distinct and signiﬁcant bacterial cluster was identiﬁed.
The mucosal microbiota structure of patients in remission
after 6 months (REM) was more complex and better organised
than the structure inferred for patients suffering from disease
recurrence (REC) (ﬁgure 3). The REM microbiota structure was
composed of 192 OTUs, whereas 102 OTUs were found in the
REC structure (see online supplementary tables S4 and S5,
respectively) with 82 OTUs common to both structures. The
number of inter-OTUs correlations was ﬁve times higher for
REM microbiota (2142) compared with REC one (436). Both
REM and REC network structures were made up of ﬁve signiﬁ-
cant clusters. Each microbial cluster was well distributed in the
cohort of patients, either patients in remission (see online sup-
plementary ﬁgure S4A) or with recurrence (see online supple-
mentary ﬁgure S4B).
Among the ﬁve REM microbial clusters, clusters I, III and IV
were made up of bacteria mainly related to Firmicutes phylum
(70%, 67% and 63%, respectively). Main species in cluster I
Figure 2 Early bacterial biomarkers of the clinical outcome after ileocolonic resection (ICR). Faecal microbiota from 10 patients was analysed at
M0 and 6 months after ICR. (A) Speciﬁc bacterial operational taxonomic units (OTUs) that may predict at M0 the clinical outcome following ICR
were deciphered applying the LEfSe algorithm.47 The LEfSe algorithm uses the non-parametric factorial Kruskal–Wallis sum-rank test to detect
features with signiﬁcant differential abundance with respect to the clinical outcome; biological signiﬁcance is subsequently investigated using a set
of pairwise tests using the (unpaired) Wilcoxon rank-sum test. As a last step, LEfSe uses linear discriminant analysis to estimate the effect size of
each differentially abundant feature (ie, bacterial OTUs). (B) Boxplot of the distribution (per cent of total reads) of the four OTUs highlighted in the
LEfSe analyses in the different patients’ groups. M0 bacterial biomarkers associated with remission at M6 are in green. M0 bacterial biomarkers of
future recurrence in patients undergoing ICR are in red. M0, samples at time of surgery; REC, recurrence; REM, remission; LDA, linear discriminant
analysis.
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related to Faecalibacterium prausnitzii, Ruminococcus bromii
and B. plebeius, whereas G. formicilis was the main driver of
cluster III. Interestingly, cluster I represented a tight community,
mainly constituted with OTUs from the Ruminococcaceae and
Lachnospiraceae families, with each OTU sharing in average
16.45 correlations with other OTUs of the cluster. The cluster
Figure 3 Correlation network organisation inferred from the microbiota composition of patients with Crohn’s disease in remission and in
recurrence 6 months after ileocolonic resection (ICR). (A) and (B) respectively depict the correlation network structures inferred from the microbiota
composition of patients in remission or with recurrence 6 months after ICR. Each number relates to operational taxonomic unit (OTU) indexes. OTU
phylogeny at phylum level is described by colours ﬁlling each OTU dot. Correlation scores are indicated by the colour of the edges linking OTU pairs.
Polygons delineate each cluster (C1–C5) identiﬁed in the network. (A and B) The red, yellow, green, blue and purple polygons delineate clusters I, II,
III, IV and V.
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II was taxonomically more diverse and composed of Firmicutes
(49%), Bacteroidetes (34%) and Proteobacteria (11%) phyla.
The most abundant OTUs related to Dorea formicigenerans,
Sutterella wadsworthensis and Bacteroides uniformis. Finally,
cluster V grouped OTUs afﬁliated to Firmicutes (42%),
Proteobacteria (31%), Bacteroidetes (15%) and Actinobacteria
(8%). Firmicutes population showed balanced proportions of
Clostridia and Bacilli classes with OTUs related to Clostridium,
Blautia, Streptococcus, Gemella and Granulicatella genera (as
opposed to Clostridia class alone in cluster I).
On the other hand, the REC microbiota structure included
ﬁve different clusters that were looser than in the REM micro-
biota structure (average 4.27 correlations/OTUs in REC vs
11.16 correlations/OTUs in REM). The cluster II was composed
at 50% with Proteobacteria (α-/β-Proteobacteria) and OTUs
were afﬁliated to Comamonas and Pelomonas genera. The
cluster III grouped Clostridium hylemonae, Ruminococcus
gnavus and E. durans, a group of species speciﬁcally involved in
bile acids (BAs) hydroxylation and bile salts hydrolysis. F. praus-
nitzii was only detected once in cluster III, and out of ﬁve corre-
lations shared by F. prausnitzii within this cluster, four were
negative. Similarly to the microbiota of patients in remission,
two clusters enriched in Firmicutes were detected, one mainly
containing Clostridia (cluster IV) and the other Bacilli (cluster
I). Finally, the cluster V, driven mainly by Bacteroides caccae and
Eubacterium halii, grouped bacteria that were well distributed
in terms of phyla repartition.
Colonisation of the neoterminal ileum and subanastomotic
colon after ICR
Comparison between the microbiota colonising the neoterminal
ileum and the subanastomotic mucosa highlighted an average
TTGE proﬁle similarity percentage of 82.6%±21.8%.
Interestingly, dominant mucosal microbiota in the neoterminal
ileum and subanastomotic colon were signiﬁcantly closer within
the patients in remission at M6 than in patients with recurrence
(REM: 92.2±2.7; REC: 77.9%±24.7; p=0.02). A similar trend
was observed with the pyrosequencing analysis (ﬁgure 4).
Species from Dorea and Brevundimonas accounted for those
explaining this difference. D. longicatena (REC-sub: 0.265
±0.247 and REC-sus: 0.636±0.314) and Brevundimonas vesi-
cularis (REC-sub: 0.022±0.022 and REC-sus: 0.203±0.096)
were respectively 2.4-fold and 9.2-fold increased in the neo-
terminal ileum mucosa compared with the subanastomotic one
in patients with recurrence.
DISCUSSION
At time of surgery, the mucosal microbiota of patients with
active CD was rich in α-/β-Proteobacteria, Bacilli and more
largely in bacteria that are not usually found in a healthy gut
microbiota. This is in line with previous studies.30 31 While not
affecting the gut microbial diversity, ICR markedly modiﬁed the
gut mucosal microbiota. Following ICR, a fourfold increase of
Lachnospiraceae taxa was observed showing deep modiﬁcations
within the gut ecosystem. Lachnospiraceae abundance has previ-
ously been noticed to ﬂuctuate at both faecal and mucosal levels
in patients with CD with active disease.32 ICR also led to an
increase in Porphyromonadaceae levels in patients with endo-
scopic recurrence at 6 months, and this was also observed in the
jejunal mucosa of a mouse model of resection.33
It is noteworthy that microbial assemblage and recolonisation
process after ICR were associated to disease relapse or mainten-
ance of remission. Indeed, mucosal microbiota comparison of
patients being either on disease remission or recurrence
6 months after ICR has shed light on different gut ecosystem
composition and structures. Our results suggest that recovering
an eubiotic microbiota, mainly composed of Firmicutes and
Bacteroidetes, is a crucial step towards remission in patients
with CD after resection. Moreover, homogeneity in bacterial
composition at the anastomosis location might be associated
with homeostasis and remission in these patients. Compositional
differences mainly related to an increase in Bacilli abundance
during disease recurrence, whereas bacteria belonging to
Bacteroides, Dorea, Ruminococcus and Dialister genera were
more prevalent in patients in remission. We also assessed
whether speciﬁc bacterial biomarkers in faecal samples may
predict, at the time of surgery, the clinical outcome of patients
after ICR. Two OTUs, both being relatives of butyrate-
producing bacteria (ie, C. catus and Butyricicoccus sp.), were
more abundant in M0 faecal samples of patients being in remis-
sion at 6 months and undetectable at M0 in the microbiota of
patients with endoscopic recurrence at M6. On the other hand,
two OTUs were speciﬁc predictors of recurrence following ICR:
E. rangiferina and P. mirabilis. It is noteworthy that P. mirabilis
has been shown to be able to promote colitis in susceptible
animals,4 but also to induce robust interleukin-1b secretion via
the NLRP3 inﬂammasome, hence promoting inﬂammation.34
In order to study the structure and thus the interactions
among the bacterial components of mucosal microbiota, we
built a correlation network based on the relative abundance of
OTUs among the different samples. The gut microbiota struc-
ture differed signiﬁcantly whether patients’ disease evolved
towards maintenance of remission or recurrence of lesions. A
major result is the identiﬁcation of a complex mucosal ecosys-
tem made of gut commensals and associated with disease remis-
sion. At the opposite, the microbiota structure of patients
Figure 4 Microbiota recolonisation after ileocolonic resection.
Between class analysis (axis 1 and 2) visualising results from the
principal component analysis based on the operational taxonomic unit
composition in the microbiota of patients 6 months after surgery.
Samples were clustered according to remission/recurrence (REM/REC)
and location around the anastomosis (sus/sub). Samples of patients in
remission are in green (REM-sus and REM-sub). Samples of patients
with endoscopic recurrence are in red (REC-sus and REC-sub). sus,
neoterminal ileum; sub, subanastomotic colon.
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displaying CD recurrence appeared less organised. In a recent
study, Levy and Borenstein35 applied systems biology and meta-
bolic modelling to highlight forces driving species composition
in the gut microbiome. This metabolic-based prediction of
species interaction showed that habitat is the dominant structur-
ing force of the human microbiome. Here we show that CD
activity is associated with a loose and non-cohesive mucosal
microbiota structure that might impair proper ecosystem func-
tions. On the other hand, a tightly correlated and cohesive
species structure was observed in patients in remission 6 months
after ICR.
Whatever the clinical status of patients 6 months after ICR,
we observed at least one cluster containing mostly bacteria
belonging both to the phylogenetic36 and the metagenomic
core37 (REM: cluster II and III; REC: cluster V). These clusters
may constitute a functional core required for the performance
of the gut ecosystem. The microbial community structure of
patients in remission also presented a cluster mainly driven by
F. prausnitzii and R. bromii. Both species are thought to play a
beneﬁcial role in human health, partly through the production
of short-chain fatty acids (SCFAs; butyrate mostly) and were
more abundant in healthy subjects than in patients with CD .38
Moreover, F. prausnitzii has been associated with clinical beneﬁt
in CD and its anti-inﬂammatory properties have been demon-
strated in animal models.39 40 R. bromii is a strong degrader of
resistant starches and proved to be unique in stimulating starch
utilisation by other bacterial species,41 which may enhance the
production of SCFAs in this cluster. On the other hand, the
microbial structure of patients with recurrence 6 months after
ICR exhibited a cluster enriched in Proteobacteria (α-/
β-Proteobacteria) and composed of unusual bacteria that were
also detected in the mucosa of patients with IBD in several pre-
vious studies.30 31 Interestingly, another community (cluster III)
speciﬁc of REC patients was composed of bacteria sharing spe-
ciﬁc enzymatic machinery associated with the metabolism of
BAs. Hence, E. durans, a component of this cluster, exhibits bile
salt hydrolase activity42 and may deconjugate BAs. Moreover,
C. hylemonae and R. gnavus, main contributors of this cluster,
both possess a high BA 7α-dehydroxylating activity, leading to
the production of secondary BAs. Of note, high concentrations
of secondary BAs in faeces have been linked to the pathogenesis
of colon cancer and more recently to CD,43 and several studies
also reported increased R. gnavus proportions in the mucosa
and in faeces of patients with CD.44–46
Ecological forces and key bacterial species that support these
mucosal microbial communities still remain to be determined.
Yet the presented global approach may allow a better under-
standing of microbial modulation by environmental factors
(diet, prebiotics, antibiotics, pH, oxygen) but mostly pave the
way towards general microbiota ecosystem modulation on the
gut by regulating speciﬁc bacteria in the structure.
CONCLUSION
We highlighted speciﬁc bacteria, with either increased or
decreased proportions, associated with early recurrence of CD
inﬂammatory lesions. Moreover, we applied robust statistical
analysis to assess the structure (bacterial phylotypes clusters and
correlation networks) of the mucosa-associated microbial eco-
system in these patients and highlighted an overall ecosystem
disruption in patients with CD recurrence after ICR.
Looking at the level of ecosystem structure may be a critical
step in the development of therapeutic interventions targeting
the microbiota in CD, including antibiotics and/or faecal
transplantation.
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